TVGN
NASDAQ · Biotechnology
Tevogen Bio Holdings Inc
$5.90
-0.40 (-6.35%)
Open$6.35
Previous Close$6.30
Day High$6.35
Day Low$5.72
52W High$24.90
52W Low$3.64
Volume—
Avg Volume8.6K
Market Cap33.22M
P/E Ratio—
EPS$-6.80
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+255.3% upside
Current
$5.90
$5.90
Target
$20.96
$20.96
$15.05
$20.96 avg
$24.54
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 26.00M | 22.93M | 28.87M |
| Net Income | -3,802,417 | -3,978,629 | -3,915,216 |
| Profit Margin | -14.6% | -17.4% | -13.6% |
| EBITDA | -5,256,206 | -4,739,765 | -5,087,055 |
| Free Cash Flow | -3,224,852 | -2,115,724 | -2,331,954 |
| Rev Growth | +20.6% | +0.2% | +12.7% |
| Debt/Equity | 0.27 | 0.28 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $286.20 | +0.94% | 48.5 | 501.19B |
| AMGN | Amgen Inc | $435.64 | -0.72% | 25.1 | 236.00B |
| GILD | Gilead Sciences Inc | $166.43 | -0.06% | — | 208.61B |
| VRTX | Vertex Pharmaceuticals Inc | $515.02 | -1.08% | 32.6 | 129.77B |
| REGN | Regeneron Pharmaceuticals | $920.69 | -0.29% | 19.8 | 95.40B |
| ALNY | Alnylam Pharmaceuticals Inc | $143.82 | -2.71% | 7.3 | 19.80B |